Bio-Path Holdings, Inc.
BPTH
$0.10
-$0.02-16.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.90M | 4.55M | 4.70M | 4.65M | 4.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.06M | 11.54M | 11.99M | 12.40M | 13.04M |
| Operating Income | -13.06M | -11.54M | -11.99M | -12.40M | -13.04M |
| Income Before Tax | -12.32M | -9.59M | -9.89M | -10.51M | -11.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.32 | -9.59 | -9.89 | -10.51 | -11.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.32M | -9.59M | -9.89M | -10.51M | -11.60M |
| EBIT | -13.06M | -11.54M | -11.99M | -12.40M | -13.04M |
| EBITDA | -13.02M | -11.51M | -11.94M | -12.35M | -12.98M |
| EPS Basic | -2.30 | -2.90 | -7.38 | -12.24 | -17.90 |
| Normalized Basic EPS | -1.44 | -1.81 | -4.61 | -7.65 | -11.19 |
| EPS Diluted | -2.30 | -2.90 | -7.38 | -12.24 | -17.90 |
| Normalized Diluted EPS | -1.44 | -1.81 | -4.61 | -7.65 | -11.19 |
| Average Basic Shares Outstanding | 22.70M | 16.01M | 9.59M | 5.89M | 3.38M |
| Average Diluted Shares Outstanding | 22.70M | 16.01M | 9.59M | 5.89M | 3.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |